 Cortical volume and cortical thickness deficits are shared between patients with schizophrenia and bipolar disorder.
Introduction
For over a hundred years psychotic disorders have been separated into two main varieties, schizophrenia and manic-depressive psychosis. This distinction has proved highly useful clinically and has been of heuristic value. Recent neurobiological literature supports that schizophrenia and bipolar disorder share genetic 1-3 and neurocognitive characteristics 4 , supporting that the two disorders are related at the aetiological level.
An important line of research that may help to clarify the common and different neurophysiological underpinnings of both disorders is brain morphology. A number of brain studies using structural magnetic resonance imaging (sMRI) have been carried out 5, 6 . Among these, those based on voxel-based morphometry (VBM) and surface-based morphometry (SBM) are relevant as they allow characterizing the focal changes in grey matter (GM) tissue. In contrast to VBM, which identifies regional differences in GM volume, SBM allows measuring additional local features of the cortex, including cortical thickness (CT), cortical surface area (SA), gyrification index (GI), and cortical volume (CV), the later which is a product of CT and SA of every cortical region.
Notably, recent studies have found that CT and SA seem to be heritable but genetically and phenotypically independent 7, 8 , and they result from different ontogenic stages during corticogenesis 9 . In fact, it has been suggested that independent processes regulate CT and SA 7, 10 : while CT may be more influenced by environmental and neurodegenerative factors 11 , cortical SA developmental trajectories may be predominantly influenced by early neurodevelopmental and genetic factors 7, 8 . Thus, investigating SA and CT differences separately might lead to the identification of more specific imaging biomarkers that may provide greater insight into the neurobiology of psychiatric disorders.
Various studies have reported cortical thinning in schizophrenia compared to healthy subjects, especially in frontal and temporal regions 10, [12] [13] [14] [15] , however the evidence in bipolar disorder is less conclusive [16] [17] [18] [19] [20] [21] . Recently, two meta-analyses by the Enhancing Neuro Imaging Genetics Through Meta-analyses (ENIGMA) Consortium have conducted the largest studies of CT and SA in both schizophrenia and bipolar disorder.
The ENIGMA Schizophrenia Working Group compared 4474 patients with schizophrenia to 5098 healthy subjects and found widespread cortical thinning, with the largest effect sizes in frontal and temporal regions, as well as widespread smaller cortical SA without regional specificity 22 . On the other hand, the ENIGMA Bipolar Disorder Working Group involved 2447 bipolar patients and 4056 healthy controls.
Cortical gray matter was thinner in frontal, temporal and parietal regions of both brain hemispheres, and cortical SA was reduced in isolated brain regions associated with a history of psychosis 23 . Still, no meta-analysis studies based on CT and SA have been conducted comparing patients with schizophrenia and bipolar disorder.
Cortical gyrification, represented by the local gyrification index (GI), is a morphological measure that captures a developmental window different from CT and SA. It measures the amount of cortex buried within the sulcal folds as compared with the amount of visible cortex in circular regions of interest 24 . Cortical gyrification is of great interest because is thought to be determined by factors that occur early in the maturation of the brain. Thus, alterations in GI could reflect trait vulnerability to mental disorders 25 .
Gyrification studies in schizophrenia have alternately reported both decreased and increased GI, as reviewed by 26 . However, decreased GI has been the more replicated finding in recent studies 15, [27] [28] [29] [30] . Abnormal cortical gyrification has been described in patients with a first episode of psychosis, siblings of patients, as well as high-risk and at-risk individuals, suggesting it can be an imaging biomarker for psychosis 28, 31 .
Likewise, reduced GI in patients with bipolar disorder has been found in a few studies, along with progressive changes of brain gyrification in different stages of the disorder 32, 33 . As in previous studies using different brain imaging techniques, studies directly comparing gyrification patterns between schizophrenia and bipolar disorder are scarce and included small samples sizes. Decreased GI has been demonstrated in both disorders compared to healthy subjects, but it seems to be more pronounced in schizophrenia 30, 34 . By contrast, higher GI has also been described in both disorders, with psychotic bipolar patients showing higher GI in cingulate cortex compared to schizophrenia and healthy subjects 14 . Thus, further studies providing additional data are required.
The more comprehensive SBM analysis to date, in terms of CT, CV, and SA, was reported by Rimol et al 10 . They analyzed 173 patients with schizophrenia, 139 patients with bipolar disorder and 207 healthy subjects. Patients with schizophrenia showed widespread CV reduction driven by both CT and SA reductions, compared to healthy subjects. By contrast, bipolar patients only showed CT reductions in frontal, parietal and temporal regions, but there were no significant differences in CV or SA in comparison to healthy subjects. However, this finding still needs to be replicated by taking into account the total brain volume as a confounding factor in the analysis, because unlike CT, SA and CV are highly correlated with total brain volume 8 .
The profiles of cortical abnormalities in schizophrenia and bipolar disorder, and how far they resemble each other, have only been studied to a limited extent. The aim of this study is to investigate and compare the brain cortical alterations that underlie schizophrenia and bipolar disorder. To circumvent the limitations of previous studies related to examining a single or a few brain features and the lack of explicit inter-group comparisons between patients with both pathologies, in this work three groups of subjects are studied using multiple SBM features. Specifically, 128 patients with schizophrenia, 128 patients with bipolar disorder, and 127 healthy subjects are compared based on four local cortical measures: 1) cortical volume, 2) cortical thickness, 3) surface area, and 4) gyrification index. Given that the brain abnormalities occurring in these two disorders may affect multiple and distinct brain morphological features, the analysis of different metrics may be more specific and sensitive in discriminating the similarities and differences between disorders. We hypothesize that if schizophrenia and bipolar disorder share a common underlying pathophysiology, then these similarities must be also reflected on their brain structural changes.
Method

Participants
The patient sample (n=256) consisted of 128 patients with schizophrenia and 128 patients with bipolar disorder recruited from two hospitals (Hospital Benito Menni, Sant Boi de Llobregat; and Hospital Clínic in Barcelona). All patients were diagnosed using DSM-IV criteria. Patients were excluded if: (a) they were aged <18 years or >65 years, (b) had a history of brain trauma or neurological disease, and (c) had shown alcohol/substance abuse within 12 months prior to participation. Clinical evaluation also included the Positive and Negative Syndrome Scale (PANSS) 35 , and in the bipolar disorder group symptoms were also scored using the Young Mania Rating Scale (YMRS) 36 and Hamilton Depression Rating Scale HDRS-21 37 and the Montgomery-Åsberg Depression Rating Scale (MADRS) 38 . Overall severity of illness was rated using the Global Assessment of Functioning scale (GAF) 39 . Pre-morbid IQ was estimated using the Word Accentuation Test (Test de Acentuación de Palabras, TAP; 40, 41 , a word reading test requiring pronunciation of Spanish words whose accents have been removed. This test is conceptually similar to the UK National Adult Reading Test 42 and the American Wide-Range Achievement Test 43 . Patients were also required to have a current IQ in the normal range (i.e.,>70), as measured using four subtests of the Wechsler Adult Intelligence Scale III (WAIS-III: vocabulary, similarities, block design, and matrix reasoning).
Patients with schizophrenia were on treatment with antipsychotics (second generation AP n=81, first generation AP n=9; combination n=31) with a chlorpromazine equivalent doses of 585 mg/d (SD± 449) (Data missing n =7). Most of the bipolar patients were on treatment with mood stabilizers (n=100) (lithium alone or in combination n=78, valproate alone or in combination n=14, other mood stabilizers n=8) and with antidepressants (n=30) (Data missing for n=13); of them 81 were taking antipsychotics (second generation AP n=67, first generation AP n=7; combination n=7) with a chlorpromazine equivalent doses of 308 mg/d (SD ± 263) (Data missing for n=10).
A subsample of the subjects included in this study was previously included in another study by our group. Specifically, 37 patients with schizophrenia, 38 patients with bipolar disorder, and 38 healthy controls were analyzed using VBM 6 .
The control sample consisted of 127 healthy individuals selected to be age-, sex-and estimated premorbid IQ-matched to the patients and met the same exclusion criteria. All controls were recruited from non-medical staff working in the hospital, their relatives and acquaintances, plus independent sources in the community. They were questioned and excluded if they reported a history of mental illness and/or treatment with psychotropic medication. All individuals were right-handed.
All participants gave written informed consent and the study was approved by the hospital research ethics committee.
MRI data acquisition
All subjects were scanned in the same 1. 
Surface-based morphometry
Structural MRI data were analyzed with the FreeSurfer image analysis suite, (http://surfer.nmr.mgh.harvard.edu/). Briefly, the pre-processing included motion correction, removal of non-brain tissue, automated Talairach transformation, tessellation of the grey-and white-matter boundaries and surface deformation 44 . A number of deformation procedures were performed in the data analysis pipeline, including surface inflation and registration to a spherical atlas. This method uses both intensity and continuity information from the entire three-dimensional images in the segmentation and deformation procedures to produce vertex-wise representations of CT, SA, CV, and GI. The resultant maps are sensitive to sub-millimeter differences between groups and have been validated against histological data 45 . Prior to the statistical analyses, the individual CT, SA, CV, and GI maps were smoothed using a 2D Gaussian filter on the cortex with a full width at half maximum of 20 mm 46 .
All subjects included in this study
Finally, general linear models were applied to the individual maps and the intracranial volume was included as a covariate in the models 27 . As all groups are matched by age and gender, these factors were not included in the statistical model. However, we repeated the analyses and verified that the results did not change after controlling for these factors. Statistical inference was carried out with FreeSurfer tools based on non-parametric permutation testing, using a cluster-wise correction method for multiple comparisons with initial cluster-forming threshold of sig=2.6 (i.e., p < 0.0025, two tails) and 5,000 iterations applied. In these analyses, only those clusters with a corrected value of p < 0.05 were considered significant. Anatomical locations of the significant regions were determined with reference to the surface atlas included in FreeSurfer.
Results
Demographic, clinical and neuropsychological data for the patients and controls are shown in Table 1 . Differences in demographic characteristics among the groups were examined using chi-square tests for categorical variables and ANOVA tests for continuous variables. The groups were matched for age, sex and estimated premorbid IQ (TAP score).
SBM differences between patients with schizophrenia and healthy controls
There were significant differences in CV, CT, SA and GI between both groups, which always involved reductions in the patient group (see Figure 1 and Table 2 ). Patients with schizophrenia showed a widespread and bilateral pattern of reduction in CV ( Figure 1a ) including medial and orbitofrontal regions, both insula and surrounding cortex, the temporal cortices and the posterior cingulate, among other regions (see Table   2 for a complete list of affected regions). CT reductions followed a broadly similar pattern to that observed in CV ( Figure 1b ) but less extended in fronto medial regions and affecting larger areas of the temporal, parietal and occipital lobes, with enlarged abnormality in ventrolateral prefrontal and premotor cortices (see list on Table 2 ). In contrast, patient related reductions in SA were much less abundant involving only the right superior frontal cortex and a small area of the left lateral occipital cortex (see Figure 1c ). Finally, the GI had a differential pattern of bilateral abnormalities including reductions in temporal poles, superior temporal gyrus, insula, parietal areas (mainly supramarginal and postcentral gyri) and frontal caudal regions (see Figure 1d and Table   2 ).
SBM differences between patients with bipolar disorder and healthy controls
As shown in Figure 2 there were significant differences in CV and CT between patients with bipolar disorder and healthy controls. As in the previous analyses between schizophrenia patients and controls, these only involved reductions in patients and were frequently placed in the same areas. However, such reductions were clearly less marked in extension than those observed in patients with schizophrenia. Specifically, alteration of CV occurred in moderately sized clusters located in the right frontal cortex (in superior and orbitofrontal areas), temporal lobes and bilateral parietal cortex (supramarginal gyrus and adjacent areas) (see full description in Table 3 ). Cortical thinning abnormalities were slightly more prominent than those in CV, including clusters of larger extension (Figure 2b ). Both left and right hemispheres had frontal reductions in CT, mainly including parts of the medial and lateral prefrontal cortices, temporal lobes, insulae and supramarignal gyri, while the occipital cortex was only affected in two sites of the right hemisphere (see Table 3 ). Finally, in contrast to CV and CT results, patients with bipolar disorder did not show any significant area of SA or GI abnormalities when compared to healthy subjects.
SBM differences between patients with schizophrenia and bipolar disorder
The comparison between the two groups of patients revealed that patients with schizophrenia were significantly more affected in all cortical measures (i.e. all significant results in CV, CT, SA or GI involved reductions in schizophrenia) (see Figure 3 ). Specifically, there were seven clusters with significant CV differences that were primarily located in a bilateral fashion in the dorsomedial prefrontal and anterior cingulate cortex, in caudal occipital areas, both lateral sulci, right ventral posterior cingulate and right temporal pole (see Table 4 ). All clusters were placed within areas that had shown CV reductions in the healthy control vs. schizophrenia comparison (see both Figures 1a and 3a) . Similarly, albeit less abundantly, differences in CT between both disorders were also located in areas of previous schizophrenia vs. healthy subject reductions ( Figure 3b ). These mainly included abnormalities in the right dorsal cingulate, left lateral sulcus and left inferior temporal gyrus, posteriorly (see Table 4 ).
In contrast, SA results not always had such anatomical matching with areas of SA reduction found in the schizophrenia vs. healthy control comparison. However, all reported differences in SA between both disorders included areas that had shown CV differences in the same cross-disorder comparison (see Figures 3a and 3c ). These comprised both posterior occipital regions and the right ventral posterior cingulate (see Table 4 ). Finally, inter-disorder differences in GI included a cluster in the left supramarginal gyrus (which had previously shown extensive reductions in the schizophrenia vs. control comparison) but also included bilateral abnormalities in the cuneus that spread over the left precuneus and left primary visual areas and which, apart from a small fraction of the left side cluster, were not present at all in the schizophrenia vs. control comparison (see Figures 1d and 3d ).
Discussion
We found that patients with schizophrenia showed widespread CV and CT reductions compared to healthy subjects. CV reductions in medial brain structures, frontotemporal regions including the insula, and lateral occipital cortex are partially consistent with previous meta-analyses of VBM studies 5, 47 . Similarly, CT reductions have also been reported in schizophrenia in several studies 10, 12, 13 .
In our study, SA reductions in patients with schizophrenia were also found, indicating that although the reduction in CV is largely explained by cortical thinning, it is also affected by SA changes. It is worth mentioning that a previous study by our group 48 found that schizoaffective patients showed widespread CV reduction and a region of decreased SA in the left fusiform gyrus. Interestingly, this area is close to the left lateral occipital cortex, where we have reported SA reduction in patients with schizophrenia.
Additionally, our results are partially consistent with a recent ENIGMA meta-analysis, which found that patients with schizophrenia had widespread thinner cortex, with the largest effect sizes in frontal and temporal lobe regions 22 . However, opposite to our focal SA reduction findings, they found smaller but widespread SA reduction, which may be explained by a higher sensitivity to detect small changes due to larger sample size 22 . Another finding of this study is reduced GI in patients with schizophrenia compared to healthy subjects. Abnormalities were found in frontal, temporal and parietal regions. Decreased GI in the left insula, superior/middle/inferior frontal cortex, supramarginal cortex and Broca's area has been also reported in previous studies 27, 29, 49 .
Also in agreement with our results, another study based on two large independent samples of Swedish and Norwegian patients with schizophrenia showed reduced GI in the left pericentral region, comparared to healthy subjects 15 .
Patients with bipolar disorder showed reduced CV in right frontal, temporal and parietal regions compared to healthy subjects. Interestingly, abnormalities in the grey matter of the right prefrontal cortex and temporal lobe were described as the most robust in a meta-analysis of VBM studies in bipolar disorder 50 . Cortical thinning in bipolar disorder were found in similar but more extensive areas than CV. Similar areas with reduced CT have already been reported by other authors, including the left superior and middle temporal cortex 17, 21 , superior frontal cortex 17, 18, 21 , orbitofrontal cortex 18, 20 , and right parahippocampal gyrus 51 . More recently, the largest ENIGMA meta-analysis of CT and SA in bipolar disorder found evidence of widespread bilateral cortical thinning in frontal, temporal and parietal regions 23 . Longer duration of illness and medication were associated with reduced CT in these regions. Interestingly, there is a substantial overlap between some of the reported regions with the strongest effect sizes (i.e., left frontal operculum and left fusiform gyrus) and our results. In addition, opposite to our negative results in relation to SA abnormalities in bipolar patients, they found localized SA reduction in the insula. Although, it was only found in a subgroup of young adults and it was associated with a history of psychosis and medication 23 . Furthermore, no region of significant gyrification abnormalities between patients with bipolar disorder and healthy subjects were found in our study. Hence, our results point towards a reduction in the cortical volume of patients with bipolar disorder, which is exclusively explained by cortical thinning but not by changes in the surface area or gyrification pattern. Finally, it is important to mention that patients with bipolar disorder showed significant thinning of the right caudal middle frontal cortex (DLPFC). Reduced functional activation of this area has been reported in a number of functional MRI studies, e.g. 52 .
One of the main novelties of the present study concerns the direct comparison between patients with schizophrenia and bipolar disorder. This analysis is important to evaluate
to what extent the underlying cortical morphological alterations differ between these two disorders. To date, the limited number of studies that have compared both disorders usually found more grey matter deficits in schizophrenia. However, the cortical regions implicated by these deficits were rather heterogeneous across studies [53] [54] [55] [56] . In agreement with these studies, we found that CV reductions are more pronounced in patients with including the parahippocampal and fusiform gyrus, suggesting some common neuropathology 16 . Likewise, a similar bilateral cortical thinning in both groups, mainly affecting the operculum and the anterior/posterior cingulate cortex was reported in 58 .
Similar to us, these studies found a more pronounced cortical thinning in schizophrenia than in bipolar disorder, involving similar but also different regions. In this sense, our study adds more evidence to the hypothesis that thinning of the frontal cortex may represent a biological feature shared by both disorders. As was found by Hulshoff et al 51 , common areas of thinner cortex could be associated with higher genetic liabilities for both disorders.
In terms of SA, patients with schizophrenia showed smaller SA than patients with bipolar disorder in posterior brain regions, including the lingual gyrus, precuneus, cuneus and occipital cortex. It is worth noting that only one previous study attempted to compare abnormalities in CV, CT, and SA among schizophrenia, bipolar disorder, and healthy controls 10 . Our study adds two novelties to this previous study. First, in addition to these cortical metrics, we also compared the gyrification patterns. Second, we took into account the total brain volume as a confounding factor in the analyses. Our findings are partially in line with this previous study. One the one hand, in both studies patients with schizophrenia showed CV, CT and SA reductions compared with healthy subjects. Moreover, SA reductions were detected in patients with schizophrenia, but not in bipolar patients. On the other hand, however, while the SA reductions found by 10 in schizophrenia were widespread, only focal SA changes were identified in our study. The biggest discrepancy between both studies is that we found CV reductions in bipolar patients, while 10 did not. Despite CT reductions were found in patients with bipolar disorder in both studies, in 10 a nonsignificant SA increase was detected in patients which counteracted the cortical thinning. This discrepancy may be explained by differences in the statistical models used in both studies. In our study, the intra-cranial volume was included as a covariate because it is highly correlated with SA, and thus with CV 8 . If this factor is not taken into account, local morphological differences may be confounded with differences in total brain volume. The comparison between patients groups carried out in 10 found that practically all differences in CV were driven by changes in SA, while in our in study significant changes in both SA and CT were found.
In line with previous studies, suggesting that CT may be more influenced by additional environmental and neurodegenerative factors 11 , while cortical SA developmental trajectories in psychosis may be predominantly influenced by early neurodevelopmental and genetic factors 7, 8, 59 , our results support the hypothesis for a strongest neurodevelopmental disturbance in schizophrenia than in bipolar disorder, as SA reductions were only found in patients with schizophrenia.
Another main contribution of this study was the gyrification abnormalities found in patients with schizophrenia compared to bipolar disorder. In particular, we found a decreased GI in patients with schizophrenia in the left parietal and temporal cortex, as well as in both sides of the dorsal medial part of the occipital cortex. To date, only a few studies have directly compared GI between both disorders, but including small sample of patients. For instance, a previous study found that patients with schizophrenia and bipolar disorder have a similar pattern of reduced prefrontal gyrification, which was associated with cognitive impairments 34 . Another study reported an overlapping reduction in gyrification (i.e., 25%) in the lateral prefrontal cortex in both patient groups 30 . Finally, decreased GI has been observed in adolescents with psychotic bipolar disorder and schizophrenia, suggesting it may represent a shared endophenotype for psychosis 60 .
This study has some limitations. In common with other neuroimaging studies of psychosis, patients were medicated. Furthermore, our samples were made up of righthanded subjects, which may induce a sampling bias. It is important to note that lefthandedness has been found to be over-represented in schizophrenia. Moreover, our samples were recruited to be matched by age, gender and premorbid IQ and this may cause selection bias. For example, the proportion of men with schizophrenia was higher than that of women (74/54) and it caused a selection bias of the bipolar patients and healthy subjects. On the other hand, a limitation related to matching by age is that this may cause a selection bias in terms of years of evolution. Unfortunately, it is not possible to match these two variables at the same time, so we preferred to recruit age-matched participants. Finally, it is important to note that we matched by premorbid IQ and patients were also required to have a current IQ in the normal range (i.e.>70). We hope that this procedure contributed to reducing any IQ-related sampling bias. Finally, subjects with alcohol or drug abuse were excluded. Data on substance abuse in the past were not systematically collected and might have differed between the three groups. Therefore, our results should not be generalized to the whole population of patients and healthy controls but to subpopulations satisfying these clinical and demographic characteristics.
Future studies should investigate the value of cortical morphology for distinguishing major psychiatric disorders, for instance, by using machine learning algorithms as a diagnostic prediction tool in psychosis 61 . Moreover, new studies should be conducted to investigate the alterations in white matter tissue using multiple features derived from diffusion MRI data 62 allowing the individual characterization of microstructural parameters 63 and their relation to white matter genes 64 . Multi-modal studies 65 may help to provide a better understanding of the underlying neurobiology of schizophrenia and bipolar disorder, as well as a more robust biomedical background to the aetiology of either condition, which might ultimately lead to improvements in diagnosis and treatment.
Conclusions
Cortical volume and cortical thickness deficits are shared between patients with schizophrenia and bipolar disorder, suggesting that both pathologies may be affected by similar environmental and neurodegenerative factors. However, in bipolar disorder, these abnormalities are less pronounced. These results are in line with previous studies using different imaging techniques, as well as with genetics and neuropsychological studies, which point towards a shared neurobiological underpinning between both disorders. However, in schizophrenia, these abnormalities are more pronounced and may be related to psychotic symptoms. The exclusive alteration in schizophrenia of metrics related to the local geometry and curvature of the brain cortical surface suggests that this group is influenced by additional neurodevelopmental and genetic factors.
Taken together, these data point towards a shared neurobiological underpinning between both pathologies, but with additional components affecting schizophrenia.
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